Eli Lilly

YTD

ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.

CEO

David A. Ricks

CEODavid A. Ricks

Employees

47,000

Employees47,000

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1876

Founded1876

Employees

47,000

Employees47,000

LLY Key Statistics

Market cap

770.49B

Market cap770.49B

Price-Earnings ratio

69.45

Price-Earnings ratio69.45

Dividend yield

0.66%

Dividend yield0.66%

Average volume

3.80M

Average volume3.80M

High today

$815.21

High today$815.21

Low today

$800.00

Low today$800.00

Open price

$804.18

Open price$804.18

Volume

3.10M

Volume3.10M

52 Week high

$972.53

52 Week high$972.53

52 Week low

$711.40

52 Week low$711.40

LLY News

Simply Wall St 2d

Eli Lilly Sees 1.59% Rise As Jaypirca Secures Positive EU Opinion

recently announced several significant events, including promising trial results for baricitinib in treating severe alopecia areata and long-term efficacy data...

Benzinga 2d

Visa, Eli Lilly, Blackstone And A Real Estate Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said she loves Visa Inc. V and recommends buying the stock on the dip....

Quartz 2d

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture a...

Analyst ratings

83%

of 30 ratings

Buy

83.3%

Hold

13.3%

Sell

3.3%

More LLY News

TipRanks 4d

Eli Lilly’s Promising Position in Weight Management Market Drives Buy Rating

Leerink Partners analyst David Risinger has maintained their bullish stance on LLY stock, giving a Buy rating on March 10. David Risinger has given his Buy rat...

Quartz 6d

Eli Lilly's first weight-loss pill could expand access to GLP-1s around the globe, executive says

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide. “We feel that a product like an oral, orforgl...

Quartz 6d

Eli Lilly CEO David Rick’s’ pay rose to nearly $30 million in 2024

Eli Lilly (LLY) CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the most valuable pharmac...